Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 1,281,000 ordinary shares for cancellation.
- Purchase Date: August 1, 2025.
- Price Range: Lowest price paid was 359.00 pence; highest price paid was 368.40 pence.
- Volume Weighted Average Price: 364.8941 pence per share.
- Post-Transaction Capital: Registered share capital stands at 8,986,370,560 ordinary shares of £0.01 each.
- Treasury Shares: 3,880,205 shares held as treasury shares.
- Voting Rights: 8,982,490,355 ordinary shares with voting rights.
Material Changes
This transaction represents the second tranche of the share buyback programme announced on July 31, 2025. The purchase reduces the number of shares outstanding and increases the proportion of voting rights held by remaining shareholders.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of risks and contingencies beyond the standard disclaimer that the announcement does not constitute an offer for securities.
Key Facts for Investor Verification
- Verify the total number of shares purchased under the full buyback programme announced on July 31, 2025.
- Confirm the remaining authorization limit for the current buyback programme.
- Review the full breakdown of individual trades available via the London Stock Exchange link provided in the filing.
- Check subsequent filings for updates on the company's financial performance, as this 6-K does not contain earnings data.